3.82 USD
↘ 0.04 (0.91%)AT CLOSE (03:59 PM EDT)
Rezolute, Inc. Common Stock (NV)
RZLTNASDAQ • USD
3.82
↘ 0.01 (0.13%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
3.82
↘ 0.01 (0.13%)
Market: CLOSED
Rezolute, Inc. Common Stock (NV) (RZLT) is currently trading at $3.81. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place RZLT at a fair price relative to peers.
Technical & fundamental data as of Oct 26, 2026.
Open?$3.87
High?$3.89
Low?$3.73
Prev. Close?$3.86
Volume?1.5M
Avg. Volume?1.7M
VWAP?$3.80
Rel. Volume?0.90x
Bid / Ask
Bid?$3.27 × 100
Ask?$4.43 × 100
Spread?$1.16
Midpoint?$3.85
Valuation & Ratios
Market Cap?373.3M
Shares Out?96.7M
Float?85.0M
Float %?87.9%
P/E Ratio?N/A
P/B Ratio?3.71
EPS?-$0.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Employees
58
Market Cap
372.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2011-12-23
Address
275 SHORELINE DRIVE, SUITE 500
REDWOOD CITY, CA 94065
Phone: 650-206-4507
REDWOOD CITY, CA 94065
Phone: 650-206-4507
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?14
Piotroski F-Score?0/9Weak
Altman Z-Score?11.07Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?22.55%Squeeze Risk
Short Interest?19.2M
Days to Cover?10.1
Free Float85.0M
Avg Daily Volume1.9M
Settlement Date2026-10-15
Financial Health
Current Ratio?9.68Strong
Quick Ratio?9.68Strong
Cash Ratio?0.93Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.71FAIR▾
Peers100
S&P47
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-77.1%WEAK▾
S&P3
ROA?-68.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-64635000
Enterprise Value?$362.7M
Fundamentals ratios updated end of day